HuGE Literature Finder
|
||
Records 1-69
|
The molecular genetic make-up of male breast cancer.
Endocrine-related cancer 2019 Jul . Moelans Cathy B, de Ligt Joep, van der Groep Petra, Prins Pjotr, Besselink Nicolle, Hoogstraat Marlous, Ter Hoeve Natalie, Lacle Miangela, Kornegoor Robert, van der Pol Carmen, de Leng Wendy, Barbe Ellis, van der Vegt Bert, Martens John, Bult Peter, Smits Vincent Thbm, Koudijs Marco, Nijman Isaac, Voest Emile, Selenica Pier, Weigelt Britta, Reis-Filho Jorge, van der Wall Elsken, Cuppen Edwin, van Diest Paul |
|
Contribution of Massive Parallel Sequencing to Diagnosis of Hereditary Ovarian Cancer in the Czech Republic.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2019 32 (Supplementum2): 72-78. Soukupová Jana, Lhotová Klára, Zemánková Petra, Vocka Michal, Janatová Markéta, Stolarová Lenka, Borecká Marianna, Kleiblová Petra, Machácková Eva, Foretová Lenka, Koudová Monika, Lhota Filip, Tavandzis Spiros, Zikán Michal, Stránecký Viktor, Veselá Kamila, Panczak Aleš, Kotlas Jaroslav, Kleibl Zden |
|
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
|
Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers.
Oncotarget 2018 Jul 9 (55): 30649-30660. Chan Gloria H J, Ong Pei Yi, Low Jeffrey J H, Kong Hwai Loong, Ow Samuel G W, Tan David S P, Lim Yi Wan, Lim Siew Eng, Lee Soo-Ch |
|
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Jul . Yurgelun Matthew B, Chittenden Anu B, Morales-Oyarvide Vicente, Rubinson Douglas A, Dunne Richard F, Kozak Margaret M, Qian Zhi Rong, Welch Marisa W, Brais Lauren K, Da Silva Annacarolina, Bui Justin L, Yuan Chen, Li Tingting, Li Wanwan, Masuda Atsuhiro, Gu Mancang, Bullock Andrea J, Chang Daniel T, Clancy Thomas E, Linehan David C, Findeis-Hosey Jennifer J, Doyle Leona A, Thorner Aaron R, Ducar Matthew D, Wollison Bruce M, Khalaf Natalia, Perez Kimberly, Syngal Sapna, Aguirre Andrew J, Hahn William C, Meyerson Matthew L, Fuchs Charles S, Ogino Shuji, Hornick Jason L, Hezel Aram F, Koong Albert C, Nowak Jonathan A, Wolpin Brian |
|
Multicenter cross-sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations.
Oncology letters 2018 Jun 15 (6): 9420-9428. Wei Hongyi, Wang Minghao, Ou Jianghua, Jiang Weihua, Tian Fuguo, Sheng Yuan, Li Hengyu, Xu Hong, Zhang Ruishan, Guan Aihua, Wang Changqing, Jiang Hongchuan, Ren Yu, He Jianjun, Liu Jian, Huang Weiwei, Liao Ning, Cai Xiangjun, Ming Jia, Ling Rui, Xu Yan, Hu Chunyan, Zhang Jianguo, Guo Baoliang, Ouyang Lizhi, Shuai Ping, Liu Zhenzhen, Zhong Ling, Jing Ruilin, Zeng Zhen, Zhang Meng, Zhang Ting, Xuan Zhaoling, Tan Xuanni, Liang Junbin, Pan Qinwen, Chen Li, Zhang Fan, Fan Linjun, Zhang Yi, Yang Xinhua, Li Jingbo, Chen Chongjian, Jiang J |
|
Influence of tumour suppressor gene (TP53, BRCA1 and BRCA2) polymorphisms on polycystic ovary syndrome in South Indian women.
European journal of obstetrics, gynecology, and reproductive biology 2018 May 227 13-18. Siddamalla Swapna, Reddy Tumu Venkat, Govatati Suresh, Guruvaiah Praveen, Deenadayal Mamata, Shivaji Sisinthy, Bhanoori Manju |
|
No Evidence for the Pathogenicity of the BRCA2 c.6937?+?594T>G Deep Intronic Variant: A Case-Control Analysis.
Genetic testing and molecular biomarkers 2018 Jan . Dutil Julie, Godoy Lenin, Rivera-Lugo Rafael, Arroyo Nelly, Albino Elinette, Negrón Luis, Monteiro Alvaro N, Matta Jaime L, Echenique Migu |
|
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
PloS one 2018 13 (4): e0195497. Mitchell Rachel, Buckingham Lela, Cobleigh Melody, Rotmensch Jacob, Burgess Kelly, Usha Lyd |
|
Screening and characterization of BRCA2 c.156_157insAlu in Brazil: Results from 1380 individuals from the South and Southeast.
Cancer genetics 2018 12 228-229 93-97. Felicio Paula Silva, Alemar Barbara, Coelho Aline Silva, Berardinelli Gustavo Noriz, Melendez Matias Eliseo, Lengert André Van Helvoort, Miche Lli Rodrigo Depieri, Reis Rui M, Fernandes Gabriela Carvalho, Ewald Ingrid Petroni, Bittar Camila Matzenbacher, Netto Cristina Brinckmann Oliveira, Artigalas Osvaldo, Peixoto Ana, Pinheiro Manuela, Teixeira Manuel R, Vargas Fernando Regla, Dos Santos Anna Cláudia Evangelista, Moreira Miguel Angelo Martins, Ashton-Prolla Patricia, Palmero Edenir In |
|
BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
PloS one 2017 12 (11): e0187630. Alemar Bárbara, Gregório Cleandra, Herzog Josef, Matzenbacher Bittar Camila, Brinckmann Oliveira Netto Cristina, Artigalas Osvaldo, Schwartz Ida Vanessa D, Coffa Jordy, Alves Camey Suzi, Weitzel Jeffrey, Ashton-Prolla Patric |
|
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
BMC medical genomics 2017 05 10 (1): 33. Cheng Donavan T, Prasad Meera, Chekaluk Yvonne, Benayed Ryma, Sadowska Justyna, Zehir Ahmet, Syed Aijazuddin, Wang Yan Elsa, Somar Joshua, Li Yirong, Yelskaya Zarina, Wong Donna, Robson Mark E, Offit Kenneth, Berger Michael F, Nafa Khedoudja, Ladanyi Marc, Zhang Liyi |
|
Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Nov 29 (11): 1381-1389. Ring Kari L, Bruegl Amanda S, Allen Brian A, Elkin Eric P, Singh Nanda, Hartman Anne-Renee, Daniels Molly S, Broaddus Russell |
|
Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
Cancer genetics 2016 Sep 209 (9): 417-422. Alemar Bárbara, Herzog Josef, Brinckmann Oliveira Netto Cristina, Artigalás Osvaldo, Schwartz Ida Vanessa D, Matzenbacher Bittar Camila, Ashton-Prolla Patricia, Weitzel Jeffrey |
|
Reevaluation of RINT1 as a breast cancer predisposition gene.
Breast cancer research and treatment 2016 Sep 159 (2): 385-92. Li Na, Thompson Ella R, Rowley Simone M, McInerny Simone, Devereux Lisa, Goode David, Investigators LifePool, Wong-Brown Michelle W, Scott Rodney J, Trainer Alison H, Gorringe Kylie L, James Paul A, Campbell Ian |
|
Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA.
Breast cancer research and treatment 2016 Jan . Quiles Francisco, Menéndez Mireia, Tornero Eva, Del Valle Jesús, Teulé Àlex, Palanca Sarai, Izquierdo Angel, Gómez Carolina, Campos Olga, Santamaria Raül, Brunet Joan, Capellá Gabriel, Feliubadaló Lídia, Lázaro Con |
|
[Breast cancer in BRCA1/2 mutation carriers].
Ceskoslovenska patologie 2016 52 (4): 206-209. Fabian Pavel, Nenutil Rudo |
|
Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas.
PloS one 2016 11 (8): e0161438. Pinto Pedro, Peixoto Ana, Santos Catarina, Rocha Patrícia, Pinto Carla, Pinheiro Manuela, Leça Luís, Martins Ana Teresa, Ferreira Verónica, Bartosch Carla, Teixeira Manuel |
|
Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome.
Blood 2016 06 127 (26): 3387-97. Woollard Wesley J, Pullabhatla Venu, Lorenc Anna, Patel Varsha M, Butler Rosie M, Bayega Anthony, Begum Nelema, Bakr Farrah, Dedhia Kiran, Fisher Joshua, Aguilar-Duran Silvia, Flanagan Charlotte, Ghasemi Aria A, Hoffmann Ricarda M, Castillo-Mosquera Nubia, Nuttall Elisabeth A, Paul Arisa, Roberts Ceri A, Solomonidis Emmanouil G, Tarrant Rebecca, Yoxall Antoinette, Beyers Carl Z, Ferreira Silvia, Tosi Isabella, Simpson Michael A, de Rinaldis Emanuele, Mitchell Tracey J, Whittaker Sean |
|
Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing.
PeerJ 2016 4 e2162. Kang Hyunseok P, Maguire Jared R, Chu Clement S, Haque Imran S, Lai Henry, Mar-Heyming Rebecca, Ready Kaylene, Vysotskaia Valentina S, Evans Eric |
|
Identification of germline genetic mutations in patients with pancreatic cancer.
Cancer 2015 Oct . Salo-Mullen Erin E, O'Reilly Eileen M, Kelsen David P, Ashraf Asad M, Lowery Maeve A, Yu Kenneth H, Reidy Diane L, Epstein Andrew S, Lincoln Anne, Saldia Amethyst, Jacobs Lauren M, Rau-Murthy Rohini, Zhang Liying, Kurtz Robert C, Saltz Leonard, Offit Kenneth, Robson Mark E, Stadler Zsofia |
|
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Gastroenterology 2015 Sep 149 (3): 604-613.e20. Yurgelun Matthew B, Allen Brian, Kaldate Rajesh R, Bowles Karla R, Judkins Thaddeus, Kaushik Praveen, Roa Benjamin B, Wenstrup Richard J, Hartman Anne-Renee, Syngal Sap |
|
Deleterious BRCA1/2 mutations in an urban population of Black women.
Breast cancer research and treatment 2015 Aug 153 (1): 201-9. Lynce Filipa, Smith Karen Lisa, Stein Julie, DeMarco Tiffani, Wang Yiru, Wang Hongkun, Fries Melissa, Peshkin Beth N, Isaacs Claudi |
|
Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder population.
Oncology letters 2015 Jun 9 (6): 2787-2790. Ancot Frédéric, Arcand Suzanna L, Mes-Masson Anne-Marie, Provencher Diane M, Tonin Patricia |
|
BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
Familial cancer 2015 May . de Juan Inmaculada, Palanca Sarai, Domenech Asunción, Feliubadaló Lidia, Segura Ángel, Osorio Ana, Chirivella Isabel, de la Hoya Miguel, Sánchez Ana Beatriz, Infante Mar, Tena Isabel, Díez Orland, Garcia-Casado Zaida, Vega Ana, Teulé Àlex, Barroso Alicia, Pérez Pedro, Durán Mercedes, Carrasco Estela, Juan-Fita M José, Murria Rosa, Llop Marta, Barragan Eva, Izquierdo Ángel, Benítez Javier, Caldés Trinidad, Salas Dolores, Bolufer Pascu |
|
Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
JAMA oncology 2015 Apr 1 (1): 23-32. Hansford Samantha, Kaurah Pardeep, Li-Chang Hector, Woo Michelle, Senz Janine, Pinheiro Hugo, Schrader Kasmintan A, Schaeffer David F, Shumansky Karey, Zogopoulos George, Santos Teresa Almeida, Claro Isabel, Carvalho Joana, Nielsen Cydney, Padilla Sarah, Lum Amy, Talhouk Aline, Baker-Lange Katie, Richardson Sue, Lewis Ivy, Lindor Noralane M, Pennell Erin, MacMillan Andree, Fernandez Bridget, Keller Gisella, Lynch Henry, Shah Sohrab P, Guilford Parry, Gallinger Steven, Corso Giovanni, Roviello Franco, Caldas Carlos, Oliveira Carla, Pharoah Paul D P, Huntsman David |
|
Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Cancer 2015 Jan 121 (1): 25-33. Tung Nadine, Battelli Chiara, Allen Brian, Kaldate Rajesh, Bhatnagar Satish, Bowles Karla, Timms Kirsten, Garber Judy E, Herold Christina, Ellisen Leif, Krejdovsky Jill, DeLeonardis Kim, Sedgwick Kristin, Soltis Kathleen, Roa Benjamin, Wenstrup Richard J, Hartman Anne-Ren |
|
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
Breast cancer research and treatment 2015 Jan 149 (1): 223-7. Rosenthal Eric, Moyes Kelsey, Arnell Christopher, Evans Brent, Wenstrup Richard |
|
Germline TP53 mutational spectrum in French Canadians with breast cancer.
BMC medical genetics 2015 16 24. Arcand Suzanna L, Akbari Mohammed R, Mes-Masson Anne-Marie, Provencher Diane, Foulkes William D, Narod Steven A, Tonin Patricia |
|
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Genetics in medicine : official journal of the American College of Medical Genetics 2014 Nov 16 (11): 830-7. LaDuca Holly, Stuenkel A J, Dolinsky Jill S, Keiles Steven, Tandy Stephany, Pesaran Tina, Chen Elaine, Gau Chia-Ling, Palmaer Erika, Shoaepour Kamelia, Shah Divya, Speare Virginia, Gandomi Stephanie, Chao Elizabe |
|
Polymorphisms of DNA repair genes are related to the pathogenesis of myelodysplastic syndrome.
Hematological oncology 2014 Oct . Ribeiro Howard Lopes, de Oliveira Roberta Taiane Germano, Maia Allan Rodrigo Soares, Pires Ferreira Filho Luiz Ivando, de Sousa Juliana Cordeiro, Heredia Fabiola Fernandes, Magalhães Silvia Maria Meira, Pinheiro Ronald Feito |
|
BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
Cancer 2014 Jul 120 (13): 1960-7. Lucas Aimee L, Frado Laura E, Hwang Caroline, Kumar Sheila, Khanna Lauren G, Levinson Elana J, Chabot John A, Chung Wendy K, Frucht Haro |
|
Minor role of BRCA2 mutation (Exon2 and Exon11) in patients with early-onset breast cancer amongst Iranian Azeri-Turkish women.
Iranian journal of basic medical sciences 2014 Feb 17 (2): 108-11. Karimian Fathi Nahid, Shekari Khaniani Mahmood, Montazeri Vahid, Mansoori Derakhshan Si |
|
Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes.
Journal of experimental & clinical cancer research : CR 2014 33 74. Mancini-DiNardo Debora, Judkins Thaddeus, Woolstenhulme Nick, Burton Collin, Schoenberger Jeremy, Ryder Matthew, Murray Adam, Gutin Natalia, Theisen Aaron, Holladay Jayson, Craft Jonathan, Arnell Christopher, Moyes Kelsey, Roa Benjam |
|
FMR1 CGG allele length in Israeli BRCA1/BRCA2 mutation carriers and the general population display distinct distribution patterns.
Genetics research 2014 96 e11. Laitman Yael, Ries-Levavi Liat, Berkensdadt Michal, Korach Jacob, Perri Tamar, Pras Elon, Friedman Eit |
|
TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.
Hereditary cancer in clinical practice 2014 12 (1): 8. Cury Nathalia M, Ferraz Victor Ef, Silva Wilson |
|
Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
Familial cancer 2013 Dec 12 (4): 719-40. Casey Murray Joseph, Bewtra Chhanda, Lynch Henry T, Snyder Carrie, Stacy Mark, Watson Patri |
|
High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jul 19 (13): 3396-403. Lucas Aimee L, Shakya Reena, Lipsyc Marla D, Mitchel Elana B, Kumar Sheila, Hwang Caroline, Deng Liyong, Devoe Catherine, Chabot John A, Szabolcs Matthias, Ludwig Thomas, Chung Wendy K, Frucht Haro |
|
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
Cancer 2013 Jan 119 (2): 332-8. Pennington Kathryn P, Walsh Tom, Lee Ming, Pennil Christopher, Novetsky Akiva P, Agnew Kathy J, Thornton Anne, Garcia Rochelle, Mutch David, King Mary-Claire, Goodfellow Paul, Swisher Elizabeth |
|
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes.
European journal of human genetics : EJHG 2012 Dec . Feliubadaló L, Lopez-Doriga A, Castellsagué E, Del Valle J, Menéndez M, Tornero E, Montes E, Cuesta R, Gómez C, Campos O, Pineda M, González S, Moreno V, Brunet J, Blanco I, Serra E, Capellá G, Lázaro C |
|
Routine TP53 testing for breast cancer under age 30: ready for prime time?
Familial cancer 2012 Aug . McCuaig JM, Armel SR, Novokmet A, Ginsburg OM, Demsky R, Narod SA, Malkin D |
|
DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
Cancer epidemiology 2012 Apr 36 (2): 183-9. Reeves Stuart G, Meldrum Cliff, Groombridge Claire, Spigelman Allan, Suchy Janina, Kurzawski Grzegorz, Lubinski Jan, Scott Rodney |
|
Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
Breast cancer research : BCR 2012 14 (2): R66. Lee Daphne S C, Yoon Sook-Yee, Looi Lai Meng, Kang Peter, Kang In Nee, Sivanandan Kavitta, Ariffin Hany, Thong Meow Keong, Chin Kin Fah, Mohd Taib Nur Aishah, Yip Cheng-Har, Teo Soo-Hwa |
|
Prevalence of the BRCA1 founder mutation c.5266dup in Brazilian individuals at-risk for the Hereditary Breast and Ovarian Cancer Syndrome.
Hereditary cancer in clinical practice 2011 Dec 9 (1): 1. Ewald IP, Izetti PR, Vargas FR, Moreira MA, Moreira AS, Moreira-Filho CA, Cunha DR, Hamaguchi S, Camey SA, Schmidt A, Caleffi M, Koehler-Santos P, Giugliani R, Ashton-Prolla P |
|
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
British journal of haematology 2010 Dec . Rasi S, Spina V, Bruscaggin A, Vaisitti T, Tripodo C, Forconi F, De Paoli L, Fangazio M, Sozzi E, Cencini E, Laurenti L, Marasca R, Visco C, Xu-Monette ZY, Gattei V, Young KH, Malavasi F, Deaglio S, Gaidano G, Rossi D |
|
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations.
Cancer 2010 Nov . Bordeleau L, Lipscombe L, Lubinski J, Ghadirian P, Foulkes WD, Neuhausen S, Ainsworth P, Pollak M, Sun P, Narod SA |
|
BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010 Oct 20 (7): 1148-53. Bruchim Ilan, Amichay Keren, Kidron Dvora, Attias Zohar, Biron-Shental Tal, Drucker Liat, Friedman Eitan, Werner Haim, Fishman A |
|
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.
Cancer research 2010 Aug 70 (16): 6509-15. Ratner Elena, Lu Lingeng, Boeke Marta, Barnett Rachel, Nallur Sunitha, Chin Lena J, Pelletier Cory, Blitzblau Rachel, Tassi Renata, Paranjape Trupti, Hui Pei, Godwin Andrew K, Yu Herbert, Risch Harvey, Rutherford Thomas, Schwartz Peter, Santin Alessandro, Matloff Ellen, Zelterman Daniel, Slack Frank J, Weidhaas Joanne |
|
Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer.
Genetic testing and molecular biomarkers 2010 Aug 14 (4): 515-26. Guénard Frédéric, Pedneault Christopher St-Laurent, Ouellette Geneviève, Labrie Yvan, Simard Jacques, , Durocher Franci |
|
Population-based study of BRCA1/2 mutations: Family history based criteria identify minority of mutation carriers.
Neoplasma 2010 57 (3): 3. Mateju M, Stribrna J, Zikan M, Kleibl Z, Janatova M, Kormunda S, Novotny J, Soucek P, Petruzelka L, Pohlreich P |
|
Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
Carcinogenesis 2009 Nov 30 (11): 1898-902. García María J, Fernández Victoria, Osorio Ana, Barroso Alicia, Fernández Fernando, Urioste Miguel, Benítez Javi |
|
Germ-line mutations in mismatch repair genes associated with prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Sep 18 (9): 2460-7. Grindedal Eli Marie, Møller Pål, Eeles Ros, Stormorken Astrid Tenden, Bowitz-Lothe Inger Marie, Landrø Stefan Magnus, Clark Neal, Kvåle Rune, Shanley Susan, Maehle Lovi |
|
Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.
BMC cancer 2009 9 (1): 181. Desjardins Sylvie, Beauparlant Joly Charles, Labrie Yvan, Ouellette Geneviève, Durocher Francine, |
|
"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Dec 26 (34): 5530-6. Tan David S P, Rothermundt Christian, Thomas Karen, Bancroft Elizabeth, Eeles Rosalind, Shanley Susan, Ardern-Jones Audrey, Norman Andrew, Kaye Stanley B, Gore Martin |
|
Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.
Breast cancer research and treatment 2008 Apr 108 (3): 399-408. Arcand Suzanna L, Maugard Christine M, Ghadirian Parviz, Robidoux André, Perret Chantal, Zhang Phil, Fafard Eve, Mes-Masson Anne-Marie, Foulkes William D, Provencher Diane, Narod Steven A, Tonin Patricia |
|
Germline E-cadherin mutations in familial lobular breast cancer.
Journal of medical genetics 2007 Nov 44 (11): 726-31. Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel M J, Harris L N, Pinheiro H C, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber J E, Huntsman |
|
Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online.
Human mutation 2007 May 28 (5): 525-6. Ramus Susan J, Harrington Patricia A, Pye Carole, Peock Susan, Cook Margaret R, Cox Mark J, Jacobs Ian J, DiCioccio Richard A, Whittemore Alice S, Piver M Steven, EMBRACE , Easton Douglas F, Ponder Bruce A J, Pharoah Paul D P, Gayther Simon |
|
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Familial cancer 2007 6 (4): 453-61. Monnerat Christian, Chompret Agnès, Kannengiesser Caroline, Avril Marie-Françoise, Janin Nicolas, Spatz Alain, Guinebretière Jean-Marc, Marian Catalin, Barrois Michel, Boitier Françoise, Lenoir Gilbert M, Bressac-de Paillerets Brigit |
|
Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families.
Familial cancer 2007 6 (4): 483-90. Guénard Frédéric, Labrie Yvan, Ouellette Geneviève, Beauparlant Charles Joly, Bessette Paul, Chiquette Jocelyne, Laframboise Rachel, Lépine Jean, Lespérance Bernard, Pichette Roxane, Plante Marie, Durocher Francine, |
|
Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.
Cancer biology & therapy 2006 Sep 5 (9): 1098-102. Brooks Gabriel A, Stopfer Jill E, Erlichman Julie, Davidson Rebecca, Nathanson Katherine L, Domchek Susan |
|
Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Gynecologic oncology 2005 May 97 (2): 457-67. Casey Murray Joseph, Synder Carrie, Bewtra Chhanda, Narod Steven A, Watson Patrice, Lynch Henry |
|
Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
Clinical genetics 2005 Apr 67 (4): 322-9. Kataki A, Gomatos Ip, Pararas N, Armakolas A, Panousopoulos D, Karantzikos G, Voros D, Zografos G, Markopoulos C, Leandros E, Konstadoulakis |
|
Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
American journal of hematology 2005 Mar 78 (3): 203-6. Koren-Michowitz M, Friedman E, Gershoni-Baruch R, Brok-Simoni F, Patael Y, Rechavi G, Amariglio |
|
CHEK2 1100delC is not a risk factor for male breast cancer population.
International journal of cancer. Journal international du cancer 2004 Jan 108 (3): 475-6. Syrjäkoski Kirsi, Kuukasjärvi Tuula, Auvinen Anssi, Kallioniemi Olli |
|
Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women.
Gynecologic oncology 2003 Jan 88 (1): 58-61. Menczer J, Chetrit A, Barda G, Lubin F, Fishler Y, Altaras M, Levavi H, Struewing J P, Sadetzki S, Modan |
|
Mutation analysis of the CHK2 gene in families with hereditary breast cancer.
British journal of cancer 2001 Jul 85 (2): 209-12. Allinen M, Huusko P, Mäntyniemi S, Launonen V, Winqvist R |
|
A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Casopís lékar?? c?eských 2000 Oct 139 (20): 635-7. Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen |
|
BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
Genetics and molecular biology 0 39 (2): 223-31. Ewald Ingrid Petroni, Cossio Silvia Liliana, Palmero Edenir Inez, Pinheiro Manuela, Nascimento Ivana Lucia de Oliveira, Machado Taisa Manuela Bonfim, Sandes Kiyoko Abe, Toralles Betânia, Garicochea Bernardo, Izetti Patricia, Pereira Maria Luiza Saraiva, Bock Hugo, Vargas Fernando Regla, Moreira Miguel Ângelo Martins, Peixoto Ana, Teixeira Manuel R, Ashton-Prolla Patric |
|
Vitamin D receptor gene polymorphisms and male breast cancer risk in Turkish population.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 16 (4): 640-5. Kizildag S, Gulsu E, Bagci O, Yuksel E, Canda |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 21, 2019
- Content source: